174
Views
23
CrossRef citations to date
0
Altmetric
Research Article

Effects of inducible nitric oxide synthase inhibition in bronchial vascular remodeling-induced by chronic allergic pulmonary inflammation

, , , , , , & show all
Pages 259-268 | Received 05 Mar 2010, Accepted 14 Sep 2010, Published online: 05 Apr 2011

REFERENCES

  • Phipps S, Benyahia F, Ou TT, Barkans J, Robinson DS, Kay AB: Acute allergen-induced airway remodeling in atopic asthma. Am J Respir Cell Mol Biol. 2004;31:626–632.
  • Chetta A, Zanini A, Olivieri D: Therapeutic approach to vascular remodelling in asthma. Pulm Pharmacol Ther. 2007;20:1–8.
  • Bergeron C, Al-Ramli W, Hamid Q: Remodeling in asthma. Proc Am Thorac Soc. 2009;6:301–305.
  • Dunnill MS: The pathology of asthma, with special reference to changes in the bronchial mucosa. J Clin Pathol. 1960;13:27–33.
  • Dunnill MS, Massarella GR, Anderson JA: A comparison of the quantitative anatomy of the bronchi in normal subjects, in status asthmaticus, in chronic bronchitis, and in emphysema. Thorax. 1969;24:176–179.
  • Wilson JW, Li X: The measurement of reticular basement membrane and submucosal collagen in the asthmatic airway. Clin Exp Allergy. 1997;27:363–371.
  • Salvato G: Quantitative and morphological analysis of the vascular bed in bronchial biopsy specimens from asthmatic and non-asthmatic subjects. Thorax. 2001;56:902–906.
  • Tanaka S, Tanaka H, Abe S: High dose of inhaled fluticasone reduces high levels of urinary leukotriene E4 in the early morning in mild and moderate nocturnal asthma. Chest. 2003;124:1768–1773.
  • Moreno PR, Bernardi VH, Lopez-Cuellar J, Newell JB, McMellon C, Gold HK, Palacios IF, Fuster V, Fallon JT: Macrophage infiltration predicts restenosis after coronary intervention in patients with unstable angina. Circulation. 1996;94:3098–3102.
  • Adcock IM, Caramori G, Chung KF: New targets for drug development in asthma. Lancet. 2008;372:1073–1087.
  • Walsh GM: Emerging drugs for asthma. Expert Opin Emerg Drugs. 2008;13:643–653.
  • Ricciardolo FL, Di Stefano A, Sabatini F, Folkerts G: Reactive nitrogen species in the respiratory tract. Eur J Pharmacol. 2006;533:240–252.
  • Prado CM, Leick-Maldonado EA, Arata V, Kasahara DI, Martins MA, Tiberio IF: Neurokinins and inflammatory cell iNOS expression in guinea pigs with chronic allergic airway inflammation. Am J Physiol Lung Cell Mol Physiol. 2005;288:L741–L748.
  • Prado CM, Leick-Maldonado EA, Yano L, Leme AS, Capelozzi VL, Martins MA, Tiberio IF: Effects of nitric oxide synthases in chronic allergic airway inflammation and remodeling. Am J Respir Cell Mol Biol. 2006;35:457–465.
  • Starling CM, Prado CM, Leick-Maldonado EA, Lancas T, Reis FG, Aristoteles LR, Dolhnikoff M, Martins MA, Tiberio IF: Inducible nitric oxide synthase inhibition attenuates lung tissue responsiveness and remodeling in a model of chronic pulmonary inflammation in guinea pigs. Respir Physiol Neurobiol. 2009;165:185–194.
  • Ricciardolo FL, Nijkamp F, De Rose V, Folkerts G: The guinea pig as an animal model for asthma. Curr Drug Targets. 2008;9:452–465.
  • Lancas T, Kasahara DI, Prado CM, Tiberio IF, Martins MA, Dolhnikoff M: Comparison of early and late responses to antigen of sensitized guinea pig parenchymal lung strips. J Appl Physiol. 2006;100:1610–1616.
  • Angeli P, Prado CM, Xisto DG, Silva PL, Passaro CP, Nakazato HD, Leick-Maldonado EA, Martins MA, Rocco PR, Tiberio IF: Effects of chronic L-NAME treatment lung tissue mechanics, eosinophilic and extracellular matrix responses induced by chronic pulmonary inflammation. Am J Physiol Lung Cell Mol Physiol. 2008;294:L1197–L1205.
  • Tiberio IF, Leick-Maldonado EA, Miyahara L, Kasahara DI, Spilborghs GM, Martins MA, Saldiva PH: Effects of neurokinins on airway and alveolar eosinophil recruitment. Exp Lung Res. 2003;29:165–177.
  • Tiberio IF, Turco GM, Leick-Maldonado EA, Sakae RS, Paiva SO, do Patrocinio M, Warth TN, Lapa e Silva JR, Saldiva PH, Martins MA: Effects of neurokinin depletion on airway inflammation induced by chronic antigen exposure. Am J Respir Crit Care Med. 1997;155:1739–1747.
  • Laszlo F, Whittle BJ, Evans SM, Moncada S: Association of microvascular leakage with induction of nitric oxide synthase: effects of nitric oxide synthase inhibitors in various organs. Eur J Pharmacol. 1995;283:47–53.
  • Garvey EP, Oplinger JA, Furfine ES, Kiff RJ, Laszlo F, Whittle BJ, Knowles RG: 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J Biol Chem. 1997;272:4959–4963.
  • Mehta S, Drazen JM, Lilly CM: Endogenous nitric oxide and allergic bronchial hyperresponsiveness in guinea pigs. Am J Physiol. 1997;273:L656–L662.
  • Prado CM, Leick-Maldonado EA, Kasahara DI, Capelozzi VL, Martins MA, Tiberio IF: Effects of acute and chronic nitric oxide inhibition in an experimental model of chronic pulmonary allergic inflammation in guinea pigs. Am J Physiol Lung Cell Mol Physiol. 2005;289:L677–L683.
  • Cotta-Pereira G, Rodrigo FG, David-Ferreira JF: The elastic system fibers. Adv Exp Med Biol. 1977;79:19–30.
  • Prado CM, Leick-Maldonado EA, Miyamoto L, Yano LM, Kasahara DI, Martins MA, Tiberio IF: Capsaicin-sensitive nerves and neurokinins modulate non-neuronal nNOS expression in lung. Respir Physiol Neurobiol. 2008;160:37–44.
  • Laszlo F, Whittle BJ: Actions of isoform-selective and non-selective nitric oxide synthase inhibitors on endotoxin-induced vascular leakage in rat colon. Eur J Pharmacol. 1997;334:99–102.
  • Woessner JF Jr: Role of matrix proteases in processing enamel proteins. Connect Tissue Res. 1998;39:69–73; discussion 141–149.
  • Parks WC, Shapiro SD: Matrix metalloproteinases in lung biology. Respir Res. 2001;2:10–19.
  • Greenlee KJ, Werb Z, Kheradmand F: Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted. Physiol Rev. 2007;87:69–98.
  • Murphy G, Docherty Al: The matrix metalloproteinases and their inhibitors. Am J Respir Cell Mol Biol. 1992;7:120–125.
  • Hoshimo M, Nakamura Y, Sim J, Isogai S: Bronchial subepithelial fibrosis and expression of matrix metalloproteinases-9 in asthmatic airway inflammation. J Allergy Clin immunol. 1998;102:783–788.
  • Yaguchi T, Fukuda Y, Ishizaki M, Yamanaka N: Immunohistochemical and gelatin zymography studies for matrix metalloproteinases in bleomycin-induced pulmonary fibrosis. Pathol Int. 1998;48:954–963.
  • Kelly EA, Jarjour NN: Role of matrix metalloproteinases in asthma. Curr Opin Pulm Med. 2003;9:28–33.
  • Lambert E, Dasse E, Haye B, Petitfrere E: TIMPs as multifacial proteins. Crit Rev Oncol Hematol. 2004;49:187– 198.
  • Vignola AM, Chanez P, Siena L, Chiappara G, Bonsignore G, Bousquet J: Airways remodelling in asthma. Pulm Pharmacol Ther. 1998;11:359–367.
  • Araujo BB, Dolhnikoff M, Silva LF, Elliot J, Lindeman JH, Ferreira DS, Mulder A, Gomes HA, Fernezlian SM, James A, Mauad T: Extracellular matrix components and regulators in the airway smooth muscle in asthma. Eur Respir J. 2008;32:61–69.
  • Sands MF, Ohtake PJ, Mahajan SD, Takyar SS, Aalinkeel R, Fang YV, Blume JW, Mullan BA, Sykes DE, Lachina S, Knight PR, Schwartz SA: Tissue inhibitor of metalloproteinase-1 modulates allergic lung inflammation in murine asthma. Clin Immunol. 2009;130:186–198.
  • Hogaboam CM, Gallinat CS, Bone-Larson C, Chensue SW, Lukacs NW, Strieter RM, Kunkel SL: Collagen deposition in a non-fibrotic lung granuloma model after nitric oxide inhibition. Am J Pathol. 1998;153:1861–1872.
  • Meurs H, Maarsingh H, Zaagsma J: Arginase and asthma: novel insights into nitric oxide homeostasis and airway hyperresponsiveness. Trends Pharmacol Sci. 2003;24:450–455.
  • Park C-S, Krishna G, Ahn M-S, Kang J-H, Chung W-G, Kim S-J, Hwang H-K, Lee J-N, Paik S-G, Cha Y-N: Differential and constitutive expression of neuronal, inducible and endothelial nitric oxide synthase nRNAs and proteins in pathologically normal human tissues. Nitric Oxide. 2000;4:459–471.
  • Guo FH, De Raeve HR, Rice TW, Stuehr DJ, Thunnissen FB, Erzurum SC: Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo. Proc Natl Acad Sci U S A. 1995;92:7809–7813.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.